Company / Gross Margin
Enovis Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
59.8%
FY2025
5-year range
53.9% / 59.8%
FY2021-FY2025
Trend
+6.8%
vs FY2024
Sector context
#44 of 96
Health Care
What the data says
At 59.8%, Enovis's gross margin ranks #44 of 96 in the Health Care sector. Gross Margin has increased for 3 consecutive years, from 53.9% in FY2022 to 59.8% in FY2025.
Based on SEC 10-K filings.
59.8% in FY2025 with a 5-year CAGR of +26.6%.
Improved from 54.5% to 59.8% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +6.0pp
- 5-Year Change
- +26.6pp
- 10-Year Change
- -
Sector benchmark
#44 of 96 in Health CareTop 46% of 96This company 59.8% Sector average 53.6%
▼
+11.7% above sector average
Key checks
Key Insights
- Enovis's gross margin has grown for 3 consecutive years.
- In FY2025, gross margin increased 6.8% year-over-year.
- Currently 6.3pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 59.8% | +6.8% |
| FY2024 | 56.0% | +2.7% |
| FY2023 | 54.5% | +1.2% |
| FY2022 | 53.9% | -1.2% |
| FY2021 | 54.5% | +64.0% |
| FY2020 | 33.3% | -4.1% |
| FY2019 | 34.7% | +4.2% |
| FY2018 | 33.3% | +6.6% |
| FY2017 | 31.2% | +0.2% |
| FY2016 | 31.1% | +0.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026